New predictive tool for assessing breast cancer risk
Harvard Stem Cell Institute (HSCI) researchers at Dana-Farber Cancer Institute (DFCI) have identified a molecular…
Browsing: Harvard Medical School
Harvard Stem Cell Institute (HSCI) researchers at Dana-Farber Cancer Institute (DFCI) have identified a molecular…